About this product
The serving provides 250 mg of Indian frankincense extract identified with boswellic acids. The formula is focused and the botanical source is clearly named.
Boswellia is commonly used to support joint comfort and a normal inflammatory response through its boswellic acids. A focused formula makes that purpose easy to understand, although active-marker disclosure determines how confidently the extract can be compared.
The extract is slightly below the common standard-extract range, and neither boswellic-acid concentration, AKBA level, nor absorption support is stated. The 30-serving capsule supply should therefore be judged by active-form clarity and suitability, not just the listed botanical weight.
Pros
The formula is focused and the botanical source is clearly named 30 servings per container Single-ingredient design keeps the purpose clear
Cons
The extract is slightly below the common standard-extract range, and neither boswellic-acid concentration, AKBA level, nor absorption support is stated. Single-botanical scope does not cover cartilage structure or joint lubrication. Capsule-only delivery may not suit people who avoid pills.
Warnings
Boswellia may add to bleeding tendency with anticoagulant or antiplatelet medicines, so this specific combination warrants medication review. Count other Boswellia products when assessing total daily intake because the active boswellic-acid and AKBA yields may not be fully disclosed. A new rash, digestive upset, or other persistent intolerance after starting Boswellia warrants stopping use and reassessing the product.

